Last news
vivo Announces MWC 2026 Attendance; Set to Showcase New Flagship X300 Ultra

vivo Announces MWC 2026 Attendance; Set to Showcase New Flagship X300 Ultra

BARCELONA, Spain, Feb. 27, 2026 /PRNewswire/ -- vivo today announced its attendance at Mobile World Congress 2026 (MWC 2026), taking place in Barcelona from March 2 to 5. At the event, vivo will offer the first global preview of its upcoming...

Fosun International Receives "Certificate of Excellence in Environmental, Social and Governance Reporting" from Hong Kong Management Association

Fosun International Receives "Certificate of Excellence in Environmental, Social and Governance Reporting" from Hong Kong Management Association

HONG KONG, Feb. 27, 2026 /PRNewswire/ -- On 23 February 2026, The Hong Kong Management Association (HKMA) held the 2025 HKMA Best Annual Reports Awards presentation ceremony in Hong Kong. Fosun International received the "Certificate of Excellence...

Australia's Most Recommended Real Estate Professionals Unveiled at 2026 RateMyAgent Awards

Australia's Most Recommended Real Estate Professionals Unveiled at 2026 RateMyAgent Awards

MELBOURNE, Australia, Feb. 27, 2026 /PRNewswire/ -- RateMyAgent, Australia's leading review and ratings platform, has officially announced the winners of the 2026 Agent of the Year Awards. This year's winners represent the elite echelon of the...

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output to 35 billion reads, up to Q70 quality scores,...

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 27, 2026 /PRNewswire/ -- Intravesical BCG is the standard of care (SOC) for BCG-naive high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and...

Netflix Declines to Raise Offer for Warner Bros.

Netflix Declines to Raise Offer for Warner Bros.

HOLLYWOOD, Calif., Feb. 27, 2026 /PRNewswire/ -- Netflix, Inc. today announced that it has declined to raise its offer for Warner Bros. Netflix had earlier received notice from Warner Bros. Discovery (WBD) that its Board of Directors has determined...

Jacobi Launches Suite of AI-Assisted Coding Resources to Accelerate Custom Investment Technology Development

Jacobi Launches Suite of AI-Assisted Coding Resources to Accelerate Custom Investment Technology Development

BRISBANE, Australia, Feb. 27, 2026 /PRNewswire/ -- Jacobi Strategies (Jacobi), a global leader in investment technology, today announced the launch of its AI-Assisted Coding Resources, a powerful new suite of tools designed to help investment teams...

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the...

1 ... 7 8 9 10 11 12 13 14 15 ... 3829
menu
menu